Locus Biosciences, Inc. Email Format

Biotechnology ResearchNorth Carolina, United States51-200 Employees

Locus Biosciences, Inc. is a clinical-stage biotechnology company based in Morrisville, North Carolina, focused on engineering bacteriophage-based therapies to address bacterial infections and immunology. Its LOCUS platform blends predictive artificial intelligence with automated workflows to design precision phage treatments that target specific pathogens while preserving the rest of the patient’s microbiome.

The company aims to serve patients facing difficult-to-treat bacterial diseases, including antibiotic-resistant infections and inflammatory conditions driven by pathogenic bacteria. It maintains collaborations with public and industry partners, including BARDA and CARB-X, and has pursued partnerships to develop therapies for ophthalmic infections with Viatris. Recent clinical progress includes completing the open-label portion of a Phase 2 study evaluating LBP-EC01 for uncomplicated urinary tract infections caused by drug-resistant E. coli.

Get verified Locus Biosciences, Inc. emails free

Company overview Employee directory